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I. Abstract: 
Transglutaminases (TGs) are a family of enzymes that catalyzes cross linking of proteins by 
forming covalent bonds between lysine residues and glutamine residues in different 
polypeptides. Cross-linking reactions are involved in blood clots, skin formation, 
embryogenesis and apoptosis. Clinically, they are interesting since they seem to be implicated 
in neurodegenerative diseases, tumours and celiac diseases. Transglutaminases also have a 
great potential in the food industry because of its ability to cross bind proteins that are not 
normally linked. 
A gene coding for transglutaminase from Atlantic cod was cloned into a bacterial expression 
vector pET151-D-TOPO. The recombinant plasmid was used to transform the bacterial 
expression strain BL21 and expression products were analyzed with SDS-PAGE, 
Immunoblotting and mass spectrometry analysis.  The protein was expressed in the host in the 
soluble fraction, which was confirmed by SDS PAGE, imunoblotting and mass spectrometry 
analysis. A polyhistidine tag introduced at the amino-acid terminus of the transglutaminase 
protein allowed for the purification of the protein by using His-Trap columns. Large scale 
purification of the protein was successful after optimizing the washing and eluting conditions 
of the buffer. Based on these results, the bacterial expression system successfully expressed 
transglutaminase and possible use of the enzyme as a meat-glue in food industry is 
investigated. 
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III. Abbreviations: 
APS:          Ammonium persulfate 
Asn:           Asparagine 
Asp:           Aspartic acid 
Cys:           Cysteine 
ddH2O:       Double distilled water 
His:            Histidine 
IPTG:        Isopropyl β-D-1-thiogalactopyranoside 
kDa:           kilo Dalton 
PAGE:       Polyacrylamide gel electrophoresis  
SDS:         Sodium dodecyl sulfate 
SOC:         Super Optimal broth with catabolite repression 
TGs:          Transglutaminase 
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1. Introduction: 
1.1     Cold Adapted Organisms: 
Organisms inhabit different parts of the world and have to adapt different conditions like 
temperature, salt concentration, pH, pressure, etc. The largest proportion of the Earth's 
biosphere is comprised of organisms that live in cold environments (psychrophiles) (Siddiqui 
and Cavicchioli 2006). Since nearly three quarters of the planet is covered by ocean which has 
a mean temperature of 4-5oC, many organisms are psychrophiles. In other terms, 
psychrophiles are the organisms that live permanently at temperature close to freezing zero 
and these organism include yeast which has natural propensity to grow well at low 
temperature, algae which are responsible for the red to green color of the ice layers, some 
invertebrates and polar fish which are the biggest psychrophiles (Feller 2007). 
1.2     Cold Adapted Enzymes: 
The ability of these organisms to live in cold conditions may be attributed to their ability to 
produce cold adapted enzymes. Such enzymes are characterized by an increased thermo 
sensitivity and, most of them, by a higher catalytic efficiency at low and moderate 
temperatures, when compared to their mesophilic counterparts (Georlette, Bentahir et al. 
2002). In most cases of the cold adapted enzymes, the high catalytic efficiency and reduced 
thermal stability is connected. The adaptation to cold is achieved through a reduction in the 
activation energy that possibly originates from an increased flexibility of either a selected area 
or of the overall protein structure (D'Amico, Claverie et al. 2002). Due to these unique 
characteristics of these enzymes, it has been an attraction in the field of enzyme technology 
and industrial biotechnology. Apart from that, this enzyme could be a model for the study of 
protein folding, protein flexibility, stability and catalysis.  
Due to their reduced stability and high catalytic efficiency, these enzymes are a potential 
alternative to mesophilic enzymes in the field of industrial biotechnology. The fact that these 
enzymes function at low temperature and it could be easily deactivated (due to its reduced 
stability) make them good candidates to replace other widely used mesophilic enzymes. 
Proteases, lipases, amylases and cellulases are few of the enzymes that are being used as 
ingredients in some of the industrial products like detergents, clothing, food etc. In food 
industry, cold adapted enzymes like β-galactosidase has been used to remove lactose at low 
temperature. Proteases from cold adapted organisms are used in the meat industry to tenderize 
the meat at low temperature. Cold adapted enzymes could be used in brewing, cheese 
manufacturing. The only drawback for the use of cold adapted enzymes could be its 
instability. But this problem could be overcome with the use of side directed mutagenesis and 
recombinant enzyme which show improvement in the stability of the enzyme (Narinx, Baise 
et al. 1997).    
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1.3 Transglutaminase: 
Transglutaminase (TG) (protein-glutamine γ-glutamyl-transferase, E.C. 2.3.2.13) is an 
enzyme that catalyses the acyl transfer between the γ-carboxyamide groups of glutamine (Q) 
residues within peptides and the primary amino groups of various amines, where a glutamine 
residue serves as a acyl donar and the most common acyl acceptors are the ε-amino groups of 
peptide-bound lysine (K) residues or primary amino groups of naturally occuring polyamines 
(Noguchi, Ishikawa et al. 2001). When the ε-amino group of  lysine or lysyl residue acts as a 
acyl acceptor, ε-(γ-glutamyl)lysine crosslinks are formed. Apart from the crosslink between 
glutamine and lysine residues in proteins, TG is invovled in two other reactions. In the 
presence of primary amine, TG can cross link glutamine residue of the protein to the primary 
amine which is known as acyl transfer reaction. In the absence of lysine or primary amine, TG 
catalyses the reaction between water and glutamine, resulting in the deamidation of the 
glutamine residue. . In all the reactions, ammonia (NH3) is liberated. All the three reaction 
catalyzed by TG is shown in the Figure 1. 
 
 
 
 
 
Figure 1. TG catalysed reactions; A: reaction between glutamine (Q) and lysine (K). B: reaction between a 
glutamine (Q) and a polyamine. C: Reaction between Glutamine (Q) and water. The figure is taken from 
(Esposito and Caputo 2005) 
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Transglutaminase are found in various organisms such as mammals, fish, bacteria and plants. 
But the most diverse and studied TGs are from mammals. 
 
Mammalian TGs: 
Mammalian TGs are distributed in various parts of the body. They are found in blood plasma, 
platelets, erythrocytes, prostrate etc. Nine TGs genes have been identified in humans, eight of 
which encode active enzymes and six have been isolated and characterized at protein level 
(Esposito and Caputo 2005). The list of  mammalian TGs are shown in the table below. 
Table 1: Lists of mammalian TGs found: 
Name Molecular weight 
(kDa) 
Tissue Location 
TG1 90 Epithelia 
 
Cytosolic, membrane 
TG2 80 Ubiquitous 
 
Cytosolic, nuclear, 
extracellular 
TG3 77 Epithelia Cytosolic 
TG4 77 Prostate Extracellular 
TG5 81 Epithelia Cytosolic 
TG6 Unknown Unknown Unknown 
TG7 80 Ubiquitous Unknown 
Factor XIIIA 83 Blood plasma, 
platelet 
Extracellular 
Band 4.2 77 Erythrocytes Membrane 
Source (Esposito and Caputo 2005) 
 
All the mammalian TGs, except a catalytically inactive homolog (band 4.2),  require calcium 
for their catalytic activity and all the TGs have the same amino acid sequence at their active 
site (Mehta 2005). By the structure and the sequence of the active site of the enzyme, TGs 
belong to the superfamily of papain-like cysteine proteases, all of which have the catalytic 
triad—Cysteine (Cys), Histidine (His), Aspartic acid (Asp) or Cysteine (Cys), Histidine (His), 
Asparagine acid (Asn) (Shleikin and Danilov 2011). 
Mammalian Factor XIIIa  is nowadays used to treat severe pathology as fatal bleeding, since 
its role in disease has been well assessed and the role of TGs in Alzheimer’s, Huntington’s 
and Parkinson’s disease has also been suggested (Mariniello and Porta 2005). 
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Bacterial TGs: 
Since TGs have the property of polymerization and forming isopeptide, its use in food 
industry was thought be immense. The ability of the enzyme to produce food of cheap food 
with nutritional value is one of the main cause for the researchers to isolate the enzyme since 
mammalian TGs are expensive and calcium dependent. 
In 1989, Ando and others screened for 5000 microorganisms isolated from the soil for the 
detection of transglutaminase activity and a strong transglutaminase activity was found in one 
of the strain of Streptoverticillium sp S-8112. The transglutaminase purified was found to 
have a molecular weight of 40 kDa (SDS-PAGE), isoelectric point 8.9 and optimal pH for 
reaction was found to be 6-7, and moreover it was calcium independent unlike its mammalian 
counterpart (H Ando 1989). 
Bacterial cells have the ability to survive in extreme physiological conditions and stress by 
developing a protective spore around them. Spores are complex structures composed of 
carbohydrates and cross linked proteins. ɛ-(γ-glutamyl)lysine cross links and transglutaminase 
activity have been detected  in the spore coat proteins of Bacillus subtilis (Kobayashi 1996).  
TGs from Streptoverticillium sp strain S-8112 has been isolated and its primary structure 
analyzed. The enzyme contains a sole Cysteine residue, which is essential for its catalytic 
activity and  hydropathy analysis indicated that the secondary structure of the region around 
the active site Cysteine residue is similar to those of mammalian TGs (Kanaji, Ozaki et al. 
1993). 
 
Fish TGs: 
Fishes live in a different environment that their terrestrial counterparts. They have to cope 
with extreme conditions such as low temperature, low availability of oxygen, etc. So, the 
enzymes and proteins produced in fish could be of great interest as it high catalytic efficiency 
at lower temperature, which could play an immense role in food industry. The extraction and 
purification of the fish enzyme is difficult because of commercial reasons but with the help of 
recombinant DNA technology, it can be produced in microorganisms. So, TGs from fish is of 
great interest as it catalytic efficiency in lower temperature and thermostabilty. 
A cDNA for TG from the liver of red sea bream (Pagrus major) was cloned in a vector and 
expressed in E.coli and the amino acid sequence was compared with tissue type TGs from 
guinea pig liver. The overall sequence similarity was not high but the 25 amino acid sequence 
of the active site of the enzyme was identical and the recombinant enzyme was calcium 
dependent (Yasueda, Nakanishi et al. 1995). 
In 1996, TG from the liver extract of walleye pollack (Theragra Chalcogramma) was 
purified, and the molecular weight was estimated to be 77 kDa by SDS-PAGE, the optimal 
pH and temperature was found to 9.0 and 50o C respectively and calcium was required for the 
maximum activity (Yoshiyuki Kumazawa 1996). 
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Comparison of Bacterial TGs and Fish TGs: 
A commercial tranglutaminase is sold in the market under the brand name of ActivaR TG-BP 
by Ajinomoto Co. Inc, Japan. As already noted, since this commercially available TG is from 
bacterial origin, it is calcium independent. The various TGs purified and characterized from 
fish shows that the transglutaminase require calcium for its activity. The presence of metal 
ions such as Cu2+ inhibits the activity of both types of TGs. The commercial TG showed 
optimum activity at pH 6.0- 6.5 and the optimum temperature for the activity was found to be 
40o C (Alves Macedo, Durães Sette et al. 2010). 
The transglutaminase purified from squid gills showed pH optimum at 8.0 and the optimum 
temperature for the activity was found to be 20o C (Nozawa 2001). 
 
Plant TGs: 
In plants, it is ubiquitous. It has been detected in algae and in angiosperms in different organs 
and sub-cellular compartments, chloroplasts being the best-studied organelles (Serafini-
Fracassini and Del Duca 2008). 
Both bacterial and plant TGs are found to be calcium independent. 
 
Application of TGs in food industry: 
As already noted, TGs crosslinks proteins to form polymers which are chemically and 
mechanically stronger. So TGs have a high potential in food industry to covalently link 
protein and covalently link essential amino acid to food products. This could generate food 
products which are nutrional and could be supplied to person suffering from malnutrition. 
The major area for the use of TGs could be found in milk production. Since milk contains 
casein which is a good substrate for TGs. TGs could be used to cross link the caseins in the 
milk products. This property can be used for the production of cheese, yogurt etc in food 
industry. 
The use of TGs could also be found in the sea food products such as surimi. A surimi is a fish 
based product pulverizied to a thick paste and has the property of a dense and rubbery food 
item, and it is well known that “the setting” is a very important process to produce surimi 
based products with greater water holding capacity and elasticity. There are no doubts TGs 
are able to improve the texture of the raw materials by catalyzing the formation of ɛ-(γ-
glutamyl)lysine cross-links between fish proteins which is certainly responsible for the 
elasticity and firmness of the surimi gel (Mariniello and Porta 2005).  
Meat proteins such as myosin and actin act as  good substrate for TGs. Cross linking of the 
myosin molecules lead to the gelation of the myosin which is very helpful in the preparation 
of ham and sausages.     
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Advantages of cold adapted TGs are outlined below: 
The benefits of using a cold adapted enzyme over warm adapted are outlined below. 
1. Enzyme reaction is performed at low temperature so that products are not destroyed. 
2.  The enzyme is easily inactivated at moderate temperatures after the reaction is carried 
out without destroying the products. 
3. The process can be done in low temperature meaning the quality and preservation of 
the food is more easily maintained. 
4. The operation at low temperature means that growth of bacteria is kept at a minimum. 
 
1.3    Expression of recombinant protein in E. coli: 
Bacterial expression system has been widely used in the expression of recombinant proteins. 
Prokaryotes such E.coli has been widely because of several reasons such as low cost, high 
productivity, easy manipulation, a strong knowledge about the genetics and physiology of the 
bacterial cells etc. Purification of recombinant protein is also easy when bacterial expression 
system is used. Use of other expression systems such as insect expression system, mammalian 
expression system has their own drawbacks. The insect cell line uses baculovirus to transfect 
the cell line and working with viruses is not as easy as bacteria. Mammalian cells are time 
consuming, expensive and difficult to perform at large scale.  
One major disadvantage of bacterial expression system is that the recombinant protein does 
not undergo post translational modification. The correct folding on the protein may not occur 
since the cytoplasm of the bacteria is always in a reduced condition which prevents the 
formation of disulfide bonds (Terpe 2006). 
 
1.4   Host for the expression of the recombinant protein: 
BL21 Star TM (DE3) E. coli: 
The host for the expression of the recombinant protein chosen in the experiment was BL21 
Star TM (DE3) E. coli. This strain was from the ChampionTM pET Expression System 
(Invitrogen). This expression system utilizes the elements from bacteriophage T7 and the 
strain has DE3 bacteriophage lambda lysogen inserted in its genome. This lambda DE3 
lysogen contains a part of lac operon. It includes  
a) The gene for the production of the lac repressor; lac I 
b) The T7 RNA polymerase gene under the control of lacUV5 promoter. 
c) A small portion of lacZ gene. 
 
The vector used in the expression utilizes the promoter of T7 bacteriophage that has been 
modified to contain a lac operator sequence. T7 RNA polymerase has a strong recognition for 
this promoter. So in order to transcribe the gene from the vector, the RNA polymerase has to 
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be supplied by the host strain.  T7 RNA polymerase transcribes mRNA more quickly than the 
polymerase from the host E. coli. 
 
The transcription of the T7 RNA polymerase from the host cell is controlled by the lacUV5 
promoter. So, the production of the T7 RNA polymerase has to be induced by isopropyl β-D-
thiogalactoside (IPTG). The reason for the use of lacUV5 promoter, the altered form of the 
regular lac promoter is that it eliminates the requirement of CAP/cAMP in the transcription of 
the RNA polymerase. So the expression of the RNA polymerase in the host is fully controlled 
by the presence of IPTG.  
(The text is taken from the Invitrogen Champion pET directional TOPO Expression Kits, Manual part 
no 25-0400).  
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1.5    Vector used in the expression: 
 
Vector used for the insertion of the gene of interest in this experiment was chosen as 
pET151/D-TOPO. 
 
The map of pET151/D-TOPO: 
 
 
 
Figure 1:  pET151/D-TOPO vector carries a promoter called T7/lac. This promoter contains a 
promoter for the T7 bacteriophage RNA polymerase and a lac operator.  This lac operator is 
the site where the repressor molecules bind. This operator helps to repress the expression of 
the gene until the inducer is added. Apart from repressor and operator, the vector contains 
pBR322 origin of replication. The vector contains sequences for hexa-histidine peptide and 
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V5. This epitope helps to detect the protein of interest using antibodies against them. The 
vector also contains gene for the production of a small peptide of amino acids which serves as 
a recognition site for the Tobacco Etch Virus (TEV) protease.  After the production of the 
protein, this helps in the cleavage of the protein of interest from the rest of the tags or epitope.  
The vector codes for the enzyme β-lactamase which helps in the resistance to ampicillin. In 
addition to the vector, it contains Topoisomerase I from Vaccinia virus. This enzyme helps to 
clone the gene of interest in the vector. 
(This figure and text is taken from the Invitrogen Champion pET directional TOPO Expression Kits, 
Manual part no 25-0400).  
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2. Materials: 
2.1 List of solutions according to the methods: 
Concentrations are given in Molarity (M). For simplicity, for some of the reagents, exact 
weights and volumes are specified.  
2.1.1 Competent Cells: 
• MgCl2-CaCl2 Solution: (300 ml) (80 mM MgCl2 and 20 mM CaCl2 ) 
 12 ml 2M MgCl2 
 6 ml 1M CaCl2 
 Add 282 ml ddH2O to make final volume of 300 ml. 
 
• CaCl2 Solution: 
 1ml 1M CaCl2 
 2.5 ml glycerol 
 Add 6.5 ml ddH2O to make final volume of 10 ml. 
 
 
2.1.2 Expression: 
• Luria-Bertania (LB) media: (1000 ml) 
 1% Peptone 
 0.5% Yeast Extract 
 1% NaCl 
 Solubilize in ddH2O, autoclave and store at 4oC. 
 
• 1 M KH2PO4  (100 ml) 
 13.6 g KH2PO4 in 100 ml ddH2O. 
 Autoclave and store at 4oC 
 
• 1M K2HPO4 (100 ml) 
 17.4 g K2HPO4 in 100 ml ddH2O. 
 Autoclave and store at 4oC 
 
 
• Lysis Buffer (100 ml) 
 0.3 ml of 1M KH2PO4 
 4.7 ml of 1M K2HPO4 
 2.3 g NaCl 
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 0.75 g KCl 
 10 ml glycerol 
 0.5 ml Triton X-100 
 Mixed thoroughly in 90 ml ddH2O. Adjust the pH to 7.8 and bring the volume 
to 100 ml. 
 
 
• IPTG (aqueous): 
 100 mM (aqueous); premade aliquot of 1ml and stored at -20 o C. 
 
 
• Lysozyme (aqueous): (7.5 µg/µl) 
 0.1 gram lysozyme 
 0.1 ml 1M Tris (pH 8.0) 
 9.9 ml ddH2O 
 5 ml glycerol 
 Total volume = 15 ml, aliquot 1 ml and store at -20o C. 
 
• SOC media (15 ml) 
 2% Peptone 
 0.5% Yeast Extract 
 0.05% NaCl 
 10 mM MgCl2 
 10mM MgSO4 
 20mM Glucose 
 Solubilize in 15 ml ddH2O, autoclave and aliquot and store at -20o C  
 
• Ampicillin (100 mg/ml) (1000 X stock) 
 Dissolve 1 gram ampicillin in 10 ml of ddH2O 
 Filter through 0.22µm filter 
 Aliquot and store at -20oC. 
 
2.1.3 SDS-PAGE: 
• 10% APS (aqueous) 
 1 gram of APS in 10 ml of ddH2O 
 Aliquot 1 ml at -20o C. 
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• 10% SDS (100 ml) 
 10 gram of SDS in 100 ml ddH2O. Store at room temperature. 
 
• 12% SDS Resolving gel (30 ml for 5 gels) 
 9.9 ml ddH2O. 
 12 ml 30% acrylamide mix 
 7.5ml of 1.5 M Tris (pH 8.8) 
 0.3 ml of 10% SDS 
 0.3 ml of 10% APS 
 0.012 ml of TEMED 
 Mix all the ingredients (APS and TEMED is added at the end). Mix it and cast 
the gel. Immediately add 0.5 ml of water saturated butanol at the top of each 
gel. 
 
• 8% SDS Resolving gel (30 ml for 5 gels)  
 13.9 ml ddH2O. 
 8.0 ml 30% acrylamide mix 
 7.5 ml of 1.5 M Tris (pH 8.8) 
 0.3 ml of 10% SDS 
 0.3 ml of 10% APS 
 0.018 ml of TEMED 
 Mix all the ingredients (APS and TEMED is added at the end). Mix it and cast 
the gel. Immediately add 0.5 ml of water saturated butanol at the top of each 
gel. 
 
• 5% Stacking gel ( 6 ml for 5 gels) 
 4.1 ml of ddH2O. 
 1.0 ml of 30% acrylamide mix. 
 0.75 ml of 1.0 M Tris (pH 6.8) 
 0.06 ml of 10% SDS 
 0.06 ml of 10% APS 
 0.006 ml of TEMED 
 Mix it by pipetting and apply 1 ml for 1 gel. Put the comb in for the wells. 
 
• 2X SDS Sample buffer: (10 ml) 
 2.5 ml of 0.5 M Tris-HCl (pH 6.8) 
 2.0 ml of glycerol  
 0.2 ml DTT 
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 0.02 gram of Bromophenol Blue  
 0.4 g SDS 
 Solubilize in 10 ml ddH2O, aliquot and store at -20o C. 
 
• 1X SDS Sample buffer: (10 ml) 
 1.25 ml of 0.5 M Tris-HCl (pH 6.8) 
 1.0 ml of glycerol  
 0.1 ml DTT 
 0.01 gram of Bromophenol Blue  
 0.2 g SDS 
 Solubilize in 10 ml ddH2O, aliquot and store at -20o C. 
 
• SDS Running Buffer for SDS-PAGE (1 litre) 
 3 % Tris 
 14.4% Glycine 
 10% (v/v) of SDS (stock solution of 10%) 
 Solubilize in 1000 ml of ddH2O. 
 
• 1 M Tris (pH 6.8) 1 liter.  
 121.14 gm of Tris in 900 ml ddH2O, adjust pH by HCl and adjust the volume 
upto 1000ml. 
 Store at room temperature. 
 
• 1.5 M Tris (pH 8.8) 1 liter 
 181.71 14 gm of Tris in 900 ml ddH2O, adjust pH by HCl and adjust the 
volume upto 1000ml. 
 Store at room temperature. 
 
2.1.4 Immunoblotting: 
• TBS 1X (1 liter) 
 10 ml of 1 M Tris-HCl (pH 7.5) 
 30 ml of 5 M NaCl 
 Bring the volume upto 1 litre and store at room temperature. 
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• TBS-Tween 1 X (1 liter) 
 10 ml of 1 M Tris-HCl (pH 7.5) 
 30 ml of 5 M NaCl 
 500 µl Tween-20 
 Bring the volume upto 1 litre and store at room temperature. 
 
• Blocking solution 40 ml for 2 gels 
 5 % milk powder 
 40 ml TBS 1 X 
 Mix before use 
 
• Primary antibody (1o)  solution for 2 gels, 40 ml (anti-his or anti-myc) 
 40 ml of blocking solution + 13.33 µl of primary antibody solution (to make a 
dilution of 1:3000) 
 This could be reused later and was stored at -20oC. 
 
• Secondary antibody (2o) solution for 2 gels, 30 ml 
 30 ml of blocking solution + 6 µl of secondary antibody (goat anti mouse IgG-
HRP) to make a dilution of 1:5000. 
 
• ECL1 (5 ml for 1 membrane) (tubes are covered with aluminum foil as it is light 
sensitive ) 
 250 µl of 2M Tris-HCl (pH 8.3) 
 50 µl of 250mM luminol  
 50 µl of 40 mM p-coumaracid 
 Add ddH2O to make 5 ml 
 
• ECL2 (5ml for 1 membrane)  
 250 µl of 2M Tris-HCl (pH 8.3) 
 3.05 µl of 30% hydrogen peroxide  
 Add ddH2O to make 5 ml. 
 ECL1 and ECL2 are prepared before use only. 
 
 
• Luminol (250mM): 
 Premade aliquot of 1 ml stored at -20o C. 
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• p-coumaracid (40 mM): 
 Premade aliquot of 1 ml stored at -20o C. 
 
• Transfer Buffer/Towbin buffer for western blot (900 ml) 
 96mM Glycine 
 10 mM Tris 
 ddH2O 
 Store at room temperature. 
 
• 2M Tris HCl pH 8.3 (500 ml) 
 Solubilize in ddH2O and adjust pH to 8.3 
 Autoclave and store at room temperature. 
 
• Methanol Transfer Buffer 100 ml 
 10 ml methanol 
 90 ml Transfer buffer  
 
2.1.5 Coomassie Brilliant Blue (500ml) 
 1 gram Coomassie Brilliant Blue R-250 
 37.5 % (v/v) acetic acid 
 50% (v/v) methanol 
 Add ddH2O to a volume of 500 ml 
 Store at room temperature. 
2.1.6 Destaining Coomassie Brilliant Blue solution (500 ml) 
 
 0.75 % (v/v) acetic acid 
  10% (v/v) methanol  
 Add ddH2O to a volume of 500 ml 
 Store at room temperature. 
 
 
      2.1.7 Agarose Gel Electrophoresis:  
 
• 1 % agarose gel: 
 1 gram of agarose in 100 ml of TBE buffer. 
 The mixture was heated in a microwave oven to solubilize the agar. 
 10 µl of Gel Red DNA stain was added for the purpose of visualization. 
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• TBE buffer 5X (1 liter) 
 53 gram of Tris base 
 27.5 gram of boric acid 
 20 ml of 0.5 M EDTA (pH 8.0) 
 Dissolve in 1000 ml of ddH2O. 
 
• 6X gel loading dye: 
 0.25% bromophenol blue 
 0.25% xylene cyanol FF 
 30% glycerol in ddH2O.  
 
• 1 kb DNA ladder: 
 10 µl 1 kb pluss ladder 
 20 µl loading dye 
 70 µl TE buffer (pH 8.0) 
 
 
2.1.8 Protein purification using the His tag: 
 
• Buffer A  pH 7.5 (1 liter) 
 25 mM Hepes  
 300 mM NaCl 
 10 mM imidazole  
 Add ddH2O, adjust pH to 7.5  
 Degased by magnetic stirring with vacuum for 15 minutes.  
 Store at 4o C. 
 
 
• Buffer B  pH 7.5 (1 liter) 
 25 mM Hepes  
 300 mM NaCl 
 50 mM imidazole  
 Add ddH2O, adjust pH to 7.5. 
 Degased by magnetic stirring with vacuum for 15 minutes.   
 Store at 4o C. 
 
 
• Buffer C  pH 7.5 (1 liter) 
 25 mM Hepes  
 300 mM NaCl 
 500 mM imidazole  
 Add ddH2O, adjust pH to 7.5. 
 Degased by magnetic stirring with vacuum for 15 minutes.  
 Store at 4o C. 
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3.0 Methods: 
3.1 Making competent cells: 
a) BL21 cells from -80o C were streaked on the LB plate. 
b) The plates were grown overnight at 37o C. 
c) An isolated colony was picked and transferred to 4 ml of LB media in a Falcon tube 
and grown overnight at 37o C at 250 rpm.  
d) 400 µl of overnight culture was transferred to 400 ml LB media and the cells were 
grown at 37o C until the OD600 reached 0.4. 
e) The culture was centrifuged in 2 centrifuge tubes (200 ml each) at 4o C for 10 minutes 
at 2800 g. 
f) The pellets were recovered and supernatant discarded. 
g) Each pellet was dissolved in 120 ml of MgCl2-CaCl2 solution. 
h) The mixture was centrifuged at 4o C for 10 minutes at 2800 g. 
i) The pellet was recovered and dissolved in 4 ml of CaCl2 solution. 
j) Aliquot of 500 µl were made and stored at -80o C. 
 
3.2 Expression of the recombinant protein: 
Two different temperature (37oC and 16o C) were used for recombinant protein production. 
3.2.1 Transformation and induction: 
a) 100 µl of chemically competent cells (BL21) were added to separate eppendorf tube 
and 1 µl of plasmid were added to their respective tubes. 
b)  All the tubes were kept in ice for 30 minutes. 
c) The cells were heat shocked for 30 seconds at 42o C without shaking and immediately 
transferred back to ice. 
d) 250 µl of SOC (Super Optimal Broth with Catabolite Repression) medium was added 
to all the tubes. 
e) The tubes were capped tightly and incubated at 37o C for 30 minutes with shaking at 
250 rpm. 
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f) All the transformed cells were added to different labeled falcon tubes with 10 ml LB 
medium with ampicillin (100 µg/ml). Then all tubes were then incubated at 37o C with 
shaking at 250 rpm and grown overnight.  
g) 500 µl of each culture from the overnight incubation were transferred to an 
appropriately labeled flasks containing 10 ml LB medium. The flasks were incubated 
for 2 hours at 37o C with shaking at 250 rpm until OD600 reached 0.5. 
h) Each tube containing 10ml of the culture was split to 5 ml in two tubes. One tube was 
induced with 100 µl of isopropyl β-D-thiogalactopyranoside (100 mM) (IPTG) and 
one was not induced. All the tubes were incubated at 37o C with shaking at 250 rpm 
overnight. 
i) All the overnight incubated tubes were taken and collected in different tubes with 
correct labeling.  
j) The culture was centrifuged at 6200 g for 15 minutes. The temperature was kept at 4 
to 8 o C.  
k) The medium were all discarded and the pellets were kept. 
 
3.2.2 Harvesting and Lysis: 
a) All the pellets were resuspended in 250 µl of lysis buffer. 
b) The resuspended cells were frozen (-80o C) and thawed (42o C) three times. 
c) 26 µl of lysozyme (7.5 µg/µl) was added to each tube and left on ice for 1 hour.  
d) Each of the tubes was subjected to sonication with 30 amplitude for 10 seconds (3 
times). 
e) All the cells were transferred to correctly labeled eppendrof tubes and centrifuges 
for 5 minutes at 4o C (maximum speed). 
f) The supernatant were collected in new tubes and the pellets were also kept. 
 
All the samples were now ready for the Coomassie staining and Immonudetection.  
3.2.3 Preparation of samples before running SDS gels: 
Samples containing the pellet were mixed with 500 µl of 1X SDS-PAGE sample buffer and 
boiled for 5 minutes at 95o C before running the SDS-PAGE.  
Samples containing the supernatant were mixed with equal amount of 2 X SDS-PAGE sample 
buffers and boiled for 5 minutes at 95o C before running the SDS-PAGE. 
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10 µl of samples were run along with a prestained molecular marker. The gels were 
coomassie stained and visualized. 
Two different sets of SDS-PAGE were run for pellets and supernatant and were subjected to 
immunodetection. Immunodetection were based on the use of the antibody against “his” and 
“myc” tag.  
The concentration of stacking gel was chosen to be 5% and the resolving gels were 12%. .  
 
3.3 Amplification of the plasmid: 
a) 100 µl of TOP10 chemically competent cells were mixed with 1 µl of plasmid (44). 
b) It was incubated in ice for 30 minutes. 
c) The cells were then heat shocked in a water bath for 30 seconds at 42o C (without 
shaking). 
d) The cells were immediately placed on ice. 
e) 250 µl of SOC media was added and incubated for 1 hour at 37o C at 250 rpm. 
f) 2 LB plates with ampicillin were taken. One plate was plated with 50 µl of cells and 
another was plated with 200 µl of cells. 
g) The plates were grown overnight at 37o C. 
h) 2 colonies from each plate were chosen and transferred to 5 ml of LB media with 
ampicillin (100 µg/ml). The cells were grown overnight at 37o C at 250 rpm. 
 
3.4 Purification of the plasmid:  
a) The overnight grown cells were harvested by centrifuging at 6800 x g for 3 minutes at 
room temperature in a table top centrifuge. 
b) The pellet was recovered. 
c) The pellet were resuspended in 250 µl of buffer  
d) 250 µl of buffer P2 was added and mixed thoroughly by inverting the tubes 4-6 times. 
e) Again 350 µl of buffer N3 is added and mixed thoroughly by inverting 4-6 times. 
f) The cells were centrifuged for 10 minutes at 17,900 x g in a table top centrifuge. 
g) The supernatant was applied to QIAprep spin column by pipetting. 
h) It was centrifuged for 60 seconds at 17,900 x g and the flow through was discarded. 
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i) 0.5 ml of buffer PB was added and centrifuged for 60 seconds at 17,900 x g. 
j) QIAprep spin column was washed by adding 0.75 ml of buffer PE and centrifuged for 
1 minute at 17,900 x g. 
k) Flow through was discarded and the column was centrifuged for 1 minute at 17,900 x 
g. 
l) The QIAprep column was placed in a clean 1.5 ml microcentrifuge tube and the 
plasmid was eluted with 50 µl buffer EB (10 mM Tris, pH 8.5) by centrifuging for 1 
minute at 17,900 x g.  
The procedure for the purification of plasmid was taken from QIAprep Miniprep Handbook. 
(Source:http://www.qiagen.com/literature/default.aspx?Term=QIAprep%20miniprep%20handbook
%2012/2006&LiteratureType=1) 
 
3.5 Agarose gel electrophoresis: 
Agarose gel electrophoresis was carried out to determine the length of the purified plasmid. 
a) 1% agarose gel was used for the electrophesis. 1gram of agarose was mixed in 100 ml 
of 0.5 X TBE buffer. 10 µl of GelRed nucleic acid Gel Stain was added. 
b) The samples for agarose gel electrophoresis were prepared by adding 8 µl of plasmid 
with 2 µl of 6X gel loading dye. 
c) 6 µl of 1 kb DNA ladder was used as a DNA size marker. 
d) 0.5 X TBE buffer was used as the anode and cathode buffer. 
e) The gel was run for 45 minutes at 100 V. 
f) The bands were visualized in UV lights.  
 
3.6  Determination of DNA concentration: 
The concentration of the DNA was measured by NANODROP 2000 spectrophotometer. 2µl 
of elution buffer (EB) was used as blank. 2µl of the plasmid sample was used for the 
measurement. 
 
3.7  Sequencing of the purified plasmids: 
The sequence of the purified plasmid was determined by sequencing. The samples preparation 
for the sequencing is given in the table below. Two tubes were used; one with the forward 
primer and another with the reverse primer. 
27 
 
 
Reagent for the sequencing: 
Reagent Volume Final concentration 
Plasmid 3 µl 23.4 ng/µl 
BIG Dye v 3.1 2 µl  
Primer (forward or reverse) 
T7 promoter primer (forward 
primer)  
 T7 reverse sequencing 
primer (reverse) 
1 µl 0.32 µM 
Autoclaved water 2 µl  
5X Sequencing buffer 2 µl 1X 
Total 10 µl  
 
 
After the reagents were mixed, PCR was run. 
The set up for PCR is shown below: 
Steps Temperature  Duration  
1 96o C 3 minutes  
2 96 o C 10 seconds Repeat steps 2-4 for 
25 times 
3 50 o C 5 seconds  
4 60 o C 4 minutes 
5 4 o C ∞   
 
 After the PCR was done 10 µl of autoclaved water was added. The samples were sent to 
Medisinsk Genetisk avdeling at universitetssykehuset, Nord, Norge, HF (Tromso, Norge)  
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3.8 Large scale production at 16o C: 
3.8.1 Transformation: 
a) 1 µl of the plasmid 44 (TG1) was added to tube with 100 µl of BL21 chemically 
competent cells. 
b) The whole mixture was heat shocked at 42o C for 30 seconds. 
c) It was put immediately back on ice and 250 µl of SOC media was added. 
d) The cells were grown for an hour at 37o C with shaking at 250 rpm. 
e) Each mixture was transferred to 10 ml LB media containing ampicillin (100µg/ml) 
and grown over night at 37o C with shaking at 250 rpm. 
 
3.8.2 Induction: 
a) Each tube was added to a flask containing 400 ml of LB media with ampicillin      
(100 µg/ml). The four flasks were grown at 37o C with shaking at 250 rpm for two 
hours. The optical density was checked for each flask was checked in between. When 
the optical density reached around 0.4, the flasks were taken out and induced with 
100mM IPTG. For 400 ml media, 4 ml of IPTG was used. After the induction, the 
cells were incubated over night at 16o C with shaking at 250 rpm. 
 
3.8.3 Harvesting and lysis: 
a) The overnight culture was transferred in a 250 ml tube (200 ml culture in one tube) 
and centrifuged at 6000 x g for 15 minutes at +4o C to +8o C.  
b) The supernatant were discarded and the pellets were resuspended in 20 ml lysis 
buffer. (The lysis buffer contains protease inhibitor). 
c) The mixture was transferred to a falcon tube and then frozen (-80o C) and thawed 
(42o C) for three times. 
d) 400 µl of lysozyme (7.5 µg/µl) was added to each falcon tube and kept in ice for 1 
hour. 
e) Each tube was then sonicated for 6 times for 30 seconds with amplitude of 30. 
f) The mixture was transferred to eppendorff tubes and spun at maximum speed (13000 
rpm) for 10 minutes at 4 o C. Table centrifuge was used. 
g)  The pellets were discarded and the supernatant was collected in a new falcon tube. 
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h) The supernatant was further filtered with a syringe (20 ml) and a filter unit with a 
pore size of 0.45 µM. 
i) The supernatant (extract) was kept in a fridge at 4o C  
 
3.9 Protein purification: 
For the purpose of the purification of the protein from the extract, a His trap HP column was 
chosen.  The column is immobilized with Nickel atoms which have a high affinity to the 
histidine tag. This method is called Immobilized metal affinity chromatography. The total 
volume of extract was around100 ml. The volume of extracts was divided into 40 ml in two 
tubes and the rest was kept at 4o C.  
For the first run through the column, three buffers were used named as buffer A, buffer B and 
buffer C. Buffer A contains 10mM imidazole, buffer B has 50 mM imidazole and buffer C 
has 500 mM imidazole. The entire buffer has a pH of 7.5, at this pH the bonding of the 
histidine tag and the metal is at maximum.   
The lower concentration of imidazole used in the buffer is mainly used to wash the non-
specific binding of the protein that have histidine clusters. The higher concentration of the 
imidazole (500 mM) is used to elute the recombinant protein with the histidine tag. 
The His Trap HP column is put in a stand connected to a motor that pumps buffer, extract 
from the bottle at the constant rate. The constant rate chosen here is 2ml/min. All the bottles 
containing buffers and extracts were put in ice. 
Two types of buffer B were used. One had a concentration of 50 mM imidazole and other had 
a 150 mM imidazole. All the other ingredients of the buffer were same for both. Buffer B was 
mainly used for the purpose of washing the unwanted protein which has a histidine cluster. 
 
3.9.1 Washing with buffer B (50 mM imidazole): 
The procedure is as follows: 
a) The column was washed with 20% ethanol at the rate of 2ml/min. 
b) The column was again washed with 10 ml dH2O at a constant rate.   
c) The column was washed with 10 ml of buffer A (10 mM imidazole) 
d) The column was now supplied with 40 ml of extract.  
e) The column was again washed with 10 ml of buffer A. All the flow through of steps d 
and e were stored in a bottle and named as flow through 1 (FT 1).   
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f) The column was now washed with10 ml of buffer B (50 mM imidazole). This time the 
fraction was collected in 10 different eppendorf tubes. Each tube had a volume of 
approximately 1 ml. The tubes were labeled B1, B2 to B10 
g) The final step was the use of 10 ml of buffer C (500 mM imidazole) to elute the 
protein from the His column. Just like above, the eluted samples were collected in 10 
different tubes. Each tube had a volume of 1 ml and the tubes were labeled C1, C2 to 
C10. 
 
3.9.2 Washing with buffer B (150 mM imidazole): 
h) The column was washed with 10 ml of buffer A. 
i) The column was applied with 40 ml of remaining extract. 
j) The column was applied with 10 ml of buffer A. The flow through from step i and j 
were stored in a bottle and marked flow through 2 (FT 2). 
k) The column was washed with 10 ml of buffer B (150 mM imidazole). This time the 
fractions were collected in 10 different tubes. Each tube had a volume of 1 ml. the 
tubes were labeled as B11, B12 to B20. 
l) The final step was the use of 10 ml of buffer C (500 mM imidazole) to elute the 
protein from the His column. Just like above, the eluted samples were collected in 10 
different tubes. Each tube had a volume of 1 ml and the tubes were labeled C11, C12 
to C20. 
m) The column was washed with 10 ml of dH2O. 
n) The final step was the washing of the column with 20% ethanol. 
 
All the samples were stored at 4 o C and subjected to SDS-PAGE and western blot. 
All the samples were mixed with 2X SDS sample buffer and a resolving gel concentration of 
8% was used this time. 
 
3.10 Mass Spectrometry Analysis: 
The bands seen in the coomassie staining of the SDS-PAGE were investigated for protein 
identification. The sequence of the proteins in the bands were investigated by Q-TOF (LC-
MSMS. 2 bands from the gel obtained after washing with buffer B (50 mM imidazole) and 1 
band from the elution fraction (buffer C) were excised by clean scapel (1 scapel per band was 
used), placed in clean eppendorf tubes, tightly packed and sent to Institutt for medisinsk 
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biologi Det helsevitenskapelige fakultet, Universitetet i Tromsø, Norway. The sequence for 
the protein of interest was also sent along to compare it to the protein in the band. 
 
The samples were trypsinated and analyzed on the Q-TOF (LC-MSMS).  
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4. RESULTS: 
From a cDNA library from Atlantic cod (Gadus morhua); two genes encoding 
transglutaminase have been isolated. These two genes were cloned into pET151/D-Topo 
vector and found to be correctly inserted by sequencing.  In this study these two recombinant 
constructs encoding TG-1 and TG-2 proteins were tested for recombinant expression in 
Echerichia coli (E.coli). 
 
Small scale recombinant production of the TG1 and TG2 in E.Coli at 37o C. 
Five different expression plasmids containing transglutaminase genes were made. These 
recombinant vectors were named as 44, 46, 73, 76 and 77. Vectors 44 and 46 have the gene 
for transglutaminase 1 (TG1) and rest have the gene for transglutaminase 2 (TG2). An 
additional vector containing the gene for flagellin D (Fla D) was used as a positive control 
(Hynes, Furnes et al. 2011) and a vector without an insert was used as a negative control. In 
addition to the his tag that is already present in the vector, an additional myc tag is cloned just 
downstream at the C- terminal of the TG1 and Fla D, which allowed the detection of the 
protein using anti-myc as an antibody . 
A simplified figure of the different vectors used is shown below. 
A)                                                                                     B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
pp 
  TG1 myc 6x his 
 
Vector 44 and 46 pp 
  TG2 6x his 
 
Vector 73, 76 & 77 
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C)        D)    
         
 
 
 
 
 
 
 
The different types of vectors used in the experiments. A) vector used for TG1 with “his” and “myc” tag. B) 
vector used for TG2 with “his” tag. C) vector used for FlaD myc (positive control) with “his” and “myc” tag. D) 
vector used for negative control (no insert). 
 
Seven different eppendorf tubes were labeled 44, 46, 73, 76, 77, Positive control (+ve C) and 
Negative control (–ve C). The vectors were used to transform chemically competent BL21 
cells. Both cell growth and induction of the cells with IPTG were done at 37o C. In addition, 7 
cell cultures were grown but not induced with IPTG. Since the protein of interest is expressed 
inside the host, the cells were lysed with lysozyme, freeze and thaw and sonication. The pellet 
and supernatant were separated by centrifugation. 
The pellet and supernatant fractions were analyzed for the presence of recombinant protein. 
Both samples were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and stained with coomassie blue. Protein band with a molecular weight of about 
80 kDa was observed at the pellet fraction (Figure 1; lane 7, 9, 11, 13 and 15). From the 
amino acid sequence of the protein, the molecular weight of the protein was found to be 78.3 
kDa. The molecular weight of the recombinant protein fused to its tag was about 80.3 kDa. 
This band was absent in the lane containing the sample from E. coli with empty vector (Figure 
1; lane 1 and 3; Figure 2; lane 2 and 3). In supernatant fraction, there were no indication of 
bands for TG1 and TG2 (Figure 1 and 2; lane 7, 9, 11, 13 and 15) 
pp 
  Fla D myc 6x his 
 
Positive Control pp 
6x his 
 
Negative Control 
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Figure 1: SDS-PAGE analysis of the pellet fraction from the small scale production of TG1 and TG2 in E.coli at 
37o C. Following harvesting, the pellet fraction were run on a 12% SDS-PAGE, 170 V for 1 hour and stained 
with Coomassie Brilliant Blue. The numbers at the top indicate lanes and the molecular weights of the standards 
are indicated at the left margins. Lane 1: Empty vector  without IPTG (Negative control), Lane 2: Protein ladder 
(Seeblue prestained), Lane 3: Empty vector  with IPTG (Negative control),; Lane 4: Positive control without 
IPTG; Lane 5: Positive control (Fla D myc) with IPTG; Lane 6: TG1 (44) without IPTG; Lane 7: TG1 (44) with 
IPTG; Lane 8: TG1 (46) without IPTG; Lane 9: TG1 (46) with IPTG; Lane 10: TG2 (73) without IPTG; Lane 
11: TG2 (73) with IPTG; Lane 12: TG2 (76) without IPTG; Lane 13 TG2 (76) with IPTG; Lane 14 TG2 (77) 
without IPTG; Lane 15: TG2 (77) with IPTG.  
 
Figure 1 shows the SDS-PAGE analysis of the pellet fraction from the small scale production 
of TG1 and TG2 in E. coli at 37o C.  As seen in the picture, the protein of interest TG1 and 
TG2 are produced quite well. Also the positive control (FlaD myc) is produced quite well as 
can be seen in lane 5. The protein of interest TG1 can be seen expressed and produced, as 
shown in the lane 7 and 9. The band is distinct as compared to other bands in the same lane. 
The comparison of the molecular weight of the band with the ladder suggests that the weight 
of the protein is nearly 80 kDa which is the size of the expected recombinant protein. Lane 6 
and 8 contain the samples which were not induced (without IPTG) and we clearly see from 
the figure that there are no distinct bands, which suggest that the protein was not produced. 
Lane 11, 13 and 15 also shows distinct band at about 80 kDa, which corresponds to TG2. 
Lane 10, 12 and 14 were left uninduced (without IPTG) and no distinct bands are seen in the 
molecular range of 80kDa.  
For the negative controls (vector without an insert), we do not see any distinct band. The size 
of the bands at lane 7, 9, 11, 13 and 15 shows that the protein is well expressed and is 
produced in the insoluble fraction.    
1 2 3 6 5 4 9 8 7 12 11 10 13 14 15 
50 kDa 
148 kDa 
98 kDa 
64 kDa 
36 kDa 
FlaD myc 
TG2 TG2 TG2 TG1 TG1 
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Figure 2: SDS-PAGE analysis of the supernatant fraction from the small scale production of TG1 and TG2 in 
E.coli at 37o C. Following harvesting, the supernatant fraction were run on a 12% SDS-PAGE, 170 V for 1 hour 
and stained with Coomassie Brilliant Blue. The numbers at the top indicate lanes and the molecular weights of 
the standards are indicated at the left margins. Lane 1: Protein ladder (Seeblue prestained); Lane 2: Negative 
control without IPTG, Lane 3: negative control with IPTG; Lane 4: Positive control without IPTG; Lane 5: 
Positive control (Fla D myc) with IPTG; Lane 6: TG1 (44) without IPTG; Lane 7: TG1 (44) with IPTG; Lane 8: 
TG1 (46) without IPTG; Lane 9: (TG1) with IPTG; Lane 10: TG2 (73) without IPTG; Lane 11: TG2 (73) with 
IPTG; Lane 12: TG2 (76) without IPTG; Lane 13 TG2 (76) with IPTG; Lane 14 TG2 (77) without IPTG; Lane 
15: TG2 (77) with IPTG.  
Figure 2 shows the SDS-PAGE analysis of the supernatant fraction from the small scale 
production of TG1 and TG2 in E. coli at 37o C. The bands that we are looking for in the lane 
7, 9, 11, 13 and 15 at about 80 kDa is not distinct and cannot be distinguished from other 
bands in the lane. Lane 5 also does not visibly shows the expression of the positive control 
(FlaD myc). As expected the uninduced (without IPTG) and negative controls do not show 
any bands at the desired place. This result shows that the protein of interest may or may not 
have been produced in the soluble fraction at 37oC. If it was produced, it was not produced at 
a concentration detected or distinguished by coomassie staining.    
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Immunological confirmation of the identity of the TG bands found in the pellet 
fractions. 
A primary antibody against the myc epitope was utilized in order to confirm the identity of 
the recombinant band. Immunoblotting was used for identification of the 80 kDa protein. 
After binding of the primary antibody with the proteins bound to the membrane, the 
specifically bound antibody was detected with horseradish peroxidase conjugated secondary 
antibody.  
The result from the immunoblotting of the pellet fraction showed the protein was present in 
the pellet fraction (results not shown). The immunoblotting of the supernatant fraction was 
not carried out.  
Since the coomassie staining of the SDS-PAGE showed protein in the pellet fraction, when 
expressed at 37o C, the production of recombinant protein was also carried out at 16o C to test 
if more protein would end up in the soluble fraction. 
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. 
The results from the expression of the recombinant protein at 37o C shows that the protein 
was mostly expressed in the insoluble fraction (pellet). Since the aim of this study was to 
produce the recombinant protein in the soluble fraction (supernatant). We chose to lower the 
temperature of the induction, so that the protein is produced in the soluble fraction.  
 
Small scale recombinant production of the TG1 and TG2 in E. coli at 16o C. 
 
    
‘ 
 
 
 
 
 
 
 
 
Figure 3:  SDS-PAGE analysis of the pellet fraction from the small scale production of TG1 and TG2 in E. coli 
at 16o C. Following harvesting, the pellet fractions were run on a 12% SDS-PAGE, 170 V for 1 hour and stained 
with Coomassie Brilliant Blue. The numbers at the top indicate lanes and the molecular weights of the standards 
are indicated at the left margins. Lane 1: Negative control without IPTG, Lane 2: Protein ladder, Lane 3: 
negative control with IPTG; Lane 4: Positive control without IPTG; Lane 5: Positive control ( FlaD myc) with 
IPTG; Lane 6: TG1 (44) without IPTG; Lane 7: TG1 (44) with IPTG; Lane 8: TG1 (46) without IPTG; Lane 9: 
(TG1) with IPTG; Lane 10: TG2 (73) without IPTG; Lane 11: TG2 (73) with IPTG; Lane 12: TG2 (76) without 
IPTG; Lane 13 TG2 (76) with IPTG; Lane 14 TG2 (77) without IPTG; Lane 15: TG2 (77) with IPTG. 
Figure 3 shows the SDS-PAGE analysis of the pellet fraction from the small scale production 
of TG1 and TG2 in E .coli at 16o C. The gel shows the production of the protein in the lane 5, 
7, 9, 11, 13 and 15. The bands are quite distinct and visible at their respective molecular 
weight. TG1 is shown in lane 7 and 9, TG2 is shown in the lane 11, 13 and 15 and FlaD myc 
is shown in the lane 5. The negative controls (lane 1 and 3) and the uninduced (lane 4, 6, 8, 
10, 12) shows bands but not at the desired length which was quite expected. The bands in the 
lane 5, 7, 9 11, 13 and 15 are quite distinct and bigger than the rest of the band in their 
respective lanes. This result clearly shows   that the recombinant protein was expressed when 
induced with IPTG and not produced when left uninduced.  
1 2 3 6 5 4 9 8 7 12 11 10 13 14 15 
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Figure 4: SDS-PAGE analysis of the supernatant fraction from the small scale production of TG1 and TG2 in E. 
coli at 16o C. Following harvesting, the supernatant fraction were run on a 12% SDS-PAGE, 170 V for 1 hour 
and stained with Coomassie Brilliant Blue. The numbers at the top indicate lanes and the molecular weights of 
the standards are indicated at the left margins. Lane 1: Protein ladder; Lane 2: Negative control without IPTG, 
Lane 3: negative control with IPTG; Lane 4: Positive control without IPTG; Lane 5: Positive control ( FlaD myc 
)with IPTG; Lane 6: TG1 (44) without IPTG; Lane 7: TG1 (44) with IPTG; Lane 8: TG1 (46) without IPTG; 
Lane 9: (TG1) with IPTG; Lane 10: TG2 (73) without IPTG; Lane 11: TG2 (73) with IPTG; Lane 12: TG2 (76) 
without IPTG; Lane 13 TG2 (76) with IPTG; Lane 14 TG2 (77) without IPTG; Lane 15: TG2 (77) with IPTG.  
 
Figure 4 shows the SDS-PAGE analysis of the supernatant fraction from the small scale 
production of TG1 and TG2 in E. coli at 16o C. The result shows that the positive control 
FlaD myc (lane 5) is produced well enough to be detected in the gel. The band for the positive 
control at about 40 kDa is quite distinct and separable from other bands. The positive control 
without IPTG shows no band at all at the same molecular weight. There are a lot of bands in 
lanes 7, 9, 11, 13 and 15 but are not distinct as was seen in the pellet fraction and no band at 
80kDa could be seen. The bands for the sample uninduced are also not seen at their respective 
positions which were quite expected. This result shows that the recombinant protein FlaD 
myc was still produced, but seems to be more in the insoluble fraction than in the soluble 
fraction. The production of the protein of interest in soluble fraction was further investigated 
with western blotting.  
 
 
 
 
 
1 2 3 6 5 4 9 8 7 12 11 10 13 14 15 
148 kDa 
50 kDa 
98 kDa 
64 kDa 
36 kDa 
FlaD myc 
39 
 
Immunological confirmation of the identity of the TG bands found in the pellet 
fractions. 
A primary antibody against the myc epitope was utilized in order to confirm the identity of 
the recombinant band. Immunoblotting was used for identification of the 80 kDa protein.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Immunoblot testing of TG1 using anti myc antibody (1:3000) as primary antibody and HRP conjugated 
goat anti mouse (1:5000) as a secondary antibody. Lane 1: Negative control without IPTG, Lane 2: Protein 
ladder (Seeblue presatined), Lane 3: negative control with IPTG; Lane 4: Positive control without IPTG; Lane 5: 
Positive control ( FlaD myc) with IPTG; Lane 6: TG1 (44) without IPTG; Lane 7: TG1 (44) with IPTG; Lane 8: 
TG1 (46) without IPTG; Lane 9: (TG1) with IPTG; Lane 10: TG2 (73) without IPTG; Lane 11: TG2 (73) with 
IPTG; Lane 12: TG2 (76) without IPTG; Lane 13 TG2 (76) with IPTG; Lane 14 TG2 (77) without IPTG; Lane 
15: TG2 (77) with IPTG. 
The western blot shows that the positive control (figure 6, lane 5), TG1 were produced and 
detected (figure 7, lane 7 and 9). TG2 were not seen in the blot because TG2 lacks myc 
epitope and this detection was done with the primary antibody against myc epitope.  
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Immunological confirmation of the identity of the TG bands found in the supernatant 
fractions. 
A primary antibody against the myc epitope was utilized in order to confirm the identity of 
the recombinant band. Immunoblotting was used for identification of the 80 kDa protein.  
 
 
 
 
 
 
 
 
 
 
Figure 6: Immunoblot testing of TG1 using anti myc antibody (1:3000) as primary antibody and HRP conjugated 
goat anti mouse (1:5000) as a secondary antibody. Lane 1: Protein ladder; Lane 2: Negative control without 
IPTG, Lane 3: negative control with IPTG; Lane 4: Positive control without IPTG; Lane 5: Positive control ( 
FlaD myc )with IPTG; Lane 6: TG1 (44) without IPTG; Lane 7: TG1 (44) with IPTG; Lane 8: TG1 (46) without 
IPTG; Lane 9: (TG1) with IPTG; Lane 10: TG2 (73) without IPTG; Lane 11: TG2 (73) with IPTG; Lane 12: 
TG2 (76) without IPTG; Lane 13 TG2 (76) with IPTG; Lane 14 TG2 (77) without IPTG; Lane 15: TG2 (77) 
with IPTG. 
The western blot shows that the positive control (figure 6, lane 5), TG1 were produced and 
detected (figure 6, lane 7 and 9). TG2 were not seen in the blot because TG2 lacks “myc” 
epitope and this detection was done with the primary antibody against “myc” epitope. The 
bands seen in the blot seems distinct and the when compared to the positive control (40 kDa), 
the molecular weight of the spot falls around 80 kDa, which is the desired weight. Positive 
control seems to be produced in excess amount. 
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Isolation of TG-1 plasmid (44) 
Large amount of TG-1 plasmid was isolated for expression purposes.Plasmid (44) was 
amplified and purified for the purpose of the large scale production of the recombinant 
protein.  DNA concentration was determined by both UV spectrophotometry and quantitative 
analysis on an agarsose gel. The size of the plasmid was also checked by agarose gel 
electrophoresis.  (results not shown) 
 
Determination of Plasmid concentration: 
After the isolation and purification, the concentration of the plasmid was determined by 
NANODROP spectrophotometer. The concentration was found to be 23.4 ng/µl. 
 
Verification of recombinant vector by sequencing 
Sequencing was carried out to verify the sequence of the pET151/D-TopoTG-1 plasmid. The 
junction between the vector and the transglutaminase insert was confirmed by sequence 
analysis. Furthermore sequencing showed that no mutations were introduced during the 
plasmid amplification of the TG-1 plasmid. (results not shown) 
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                   Large scale recombinant production of the TG1 in E.Coli at 16o C. 
After the results from the small scale production at 37o C and 160 C, the most consistent and 
appropriate TG was found to be TG1 and the construct number 44 was chosen to be used in 
the large scale recombinant production. 
The cells were harvested in a larger volume for the large scale. The supernatant were 
harvested while the pellets were discarded.  
 
Optimizing, the washing and the eluting conditions for the His Trap column: 
The supernatant fraction of the large scale production was utilized for the purification of the 
protein. The supernatant fraction was run through His Trap Column. The protein of interest 
and other non-specific protein of interest attach to the column. Washing buffer (buffer B) was 
used to wash the non-specific protein out of the column and elution buffer (buffer C) was 
used to elute the protein of interest. Imidazole in the buffer helps to wash and elute the 
specific and non-specific proteins from the column. So, it was necessary to determine the 
concentration of imidazole in the buffers which elutes contamination, non-specific bound 
proteins while leaving the protein of interest still attached to the column. Since we want to 
elute the protein of interest with 500 mM, we had to optimize the concentration of imidazole 
in buffer B. 
Different concentrations of imidazole in buffer B were tested with different samples. First the 
250mM of imidazole was used to wash the column. 250mM imidazole was too high for the 
washing since it eluted the protein of interest. 150 mM of imidazole and 100 mM of imidazole 
was tried for washing with the same results. Finally, as we decreased the concentration of 
imidazole to 50 mM in washing buffer B, it showed positive results. It only washed unwanted 
protein and the protein of interest was eluted with 500 mM of imidazole (buffer C).  
 
The supernatant was run in His Trap column and was first washed by the buffer containing 50 
mM imidazole and then eluted with buffer containing 500 mM imidazole. 
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10 fractions of 1 ml each was collected after wahing with buffer B. The fractions were 
analysed by SDS-PAGE and coomassie staining for the presence of  the recombinant protein. 
 
 
 
 
 
 
 
 
 
Figure 7: SDS-PAGE analysis of the fractions, collected from the His Trap column after washing with the buffer 
B (50 mM imidazole) from the large scale production of TG1 in E.coli at 16o C. Following harvesting, the 
supernatant fraction were run through His column, washed with buffer B (50 mM imidazole) and collected in 10 
fractions of 1 ml each. The fractions were run on a 8% SDS-PAGE, 170 V for 1 hour and stained with 
Coomassie Brilliant Blue. The numbers at the top indicate lanes and the molecular weights of the standards are 
indicated at the left margins. Lane 1: Protein ladder; Lane 2: Extract; Lane 3: Flow through; Lane 4: B1; Lane 5: 
B2; Lane 6: B3; Lane 7: B4; Lane 8: B5; Lane 9: B6; Lane 10: B7; Lane 11: B8; Lane 12: B9; Lane 13: B10. 
Figure 7 shows the SDS-PAGE analysis of the fractions, collected from the His Trap column 
after washing with the buffer B (50 mM imidazole) from the large scale production of TG1 in 
E.coli at 16o C. Two of the bands were sent to Tromsø for the MSMS analysis. The bands sent 
for the mass spectrometry analysis is shown in circle in the figure 7. The analysis showed that 
the bands did not have the amino acid sequence of our protein of interest and were of bacterial 
origin. This results show that the washing procedure was able to wash proteins that are non-
specifically attached to the His column.  
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After washing with 10 ml of washing buffer (Buffer B), the His Trap column was eluted with 
buffer C (500 mM imidazole). 10 ml fractions of 1 ml each were collected and analyzed by 
SDS-PAGE and coomassie staining for the presence of the recombinant protein. 
 
 
Figure 8: SDS-PAGE analysis of the fractions, collected from the His column after eluting with the buffer C 
(500 mM imidazole) from the large scale production of TG1 in E.coli at 16o C. Following harvesting, the 
supernatant fraction were run through His column, washed with buffer B (50 mM imidazole), eluted with buffer 
C (500 mM) and collected in 10 fractions of 1 ml each. The fractions were run on a 8% SDS-PAGE, 170 V for 1 
hour and stained with Coomassie Brilliant Blue. The numbers at the top indicate lanes and the molecular weights 
of the standards are indicated at the left margins. Lane 1: Extract; Lane 2: Flow Through; Lane 3: Protein 
Ladder; Lane 4: E1; Lane 5: E2; Lane 6: E3; Lane 7: E4; lane 8: E5; Lane 9: E6; Lane 10: E7; Lane 11: E8; Lane 
12: E9 and Lane 13: E10. 
Figure 8 shows the SDS-PAGE analysis of the fractions, collected from the His column after 
eluting with the buffer C (500 mM imidazole) from the large scale production of TG1 in 
E.coli at 16o C. This gel shows lesser bands than earlier fractions (washing fractions). Only 
two bands can be seen in lane 6, which was where we expected to see our protein of interest. 
The upper and lower band was excised from the gel with fresh blade, put in a new eppendorf 
tube and were sent for Q-TOF (LC- MSMS) analysis in Tromsø. The sequence of the protein 
was also sent along for the verification of the protein. Results from Tromsø showed positive 
results. The sequence of the protein in the upper band showed 100% similarity with the 
sequence of our protein of interest. (results not shown)     
 
 
 
 
 
 
 
45 
 
Immunological confirmation of the identity of the recombinant protein band. 
(Elution fraction) 
 
The eluted fraction were futhur analysed by immunoblotting for the presence of the 
recombinant protein. The gels from SDS-Page were transferred to a nitrocellulose paper and 
the paper was blocked with blocking solution, washed with primary antibody, again washed 
with seconadary antibody and a film was developed to see the presence of the recombinant 
protein. Primary antibody against his epitope was used to detect the recombinant protein and 
HRP conjugated seconadry antibody against the primary antibody was used. The time given 
for the transfer of the protein bands from the gel to the paper was incresed by 30 minutes as 
compared to earlier immunobloting.   
     
 
 
Figure 9: Immunoblot testing of TG1 using anti his antibody (1:3000) as primary antibody and HRP conjugated 
goat anti mouse (1:5000) as a secondary antibody. Lane 1: Magic Marker; Lane 2: Extract; Lane 3: Flow 
Through; Lane 4: FlaD myc; Lane 5: E1; Lane 6: E2; Lane 7: E3; Lane 8: E4; Lane 9: E5; Lane 10: E6; Lane 11: 
E7; Lane 12: E8; Lane 13: E9; Lane 14: E10.  
The blot shows that the recombinant protein was produced and only one spot can be seen in 
the elution fractions (figure 9, lane 7 ). Lane 7 shows the spot and the E3 was the sample that 
contained the recombinant protein. E3 is the same fraction that showed a band in SDS-PAGE 
gel and was sent for Q-TOF (LC-MSMS). 
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3 D structure prediction: 
I-TASSER is an internet service system which is used for the prediction of protein structure 
and function (Roy, Kucukural et al. 2010) (Zhang 2008). This server predicts the structure of 
the protein based on the amino acid sequence of the protein. For the structure of our protein of 
interest, the amino acid sequence was provided in FASTA format to 
http://zhanglab.ccmb.med.umich.edu/I-TASSER/  
The prediction of TG1 was predicted as shown in the figure below: 
 
Figure 10: Prediction of 3D structure for TG1.  
The figure shows the 3D structure of TG1 predicted by I-Tasser (Roy, Kucukural et al. 2010) 
(Zhang 2008) . The prediction with the highest C-score was chosen prior to editing and 
visualization in Rasmol.  Each chain is drawn as a smooth spectrum from blue through green, 
yellow and orangeto red. The N termini of proteins are colored blue and the C termini red. 
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5. Discussion: 
5.1 Expression at 37o C vs. 16o C: 
The demand for large amount of recombinant proteins is high for the purpose of its studies 
like structure, solubility, activity etc. The need to obtain the recombinant protein in soluble 
fraction is of great importance. Various factors such as choice of expression system, induction 
temperature, and fusion tags play important role in the solubility of the protein. This study 
was undertaken to find a suitable expression system, induction temperature and use of His tag 
(as a fusion peptide) for the production of transglutaminase from a pschyrophile organism 
(Atlantic cod).    
The recombinant protein was expressed at two different temperatures (37o C and 16o C). The 
pellet and supernatant fractions were tested with both SDS-PAGE and immunoblotting. The 
fusion partner for the protein is hexa-histidine, which is cloned just upstream of the protein of 
interest. The effect of temperature in the solubility of the recombinant protein can be seen in 
this experiment. The positive control flagellin D (FlaD myc) is relatively small protein with 
respect to the protein of interest (TG). The SDS-PAGE analysis of the supernatant fraction at 
37o C and 16o C shows that the FlaD myc was more soluble when expressed at 16o C then at 
37o C (figure 2 and 4 of result). The coomassie staining of the gel shows a visible band at 40 
kDa in figure 4 (16o C), but no visible band can be seen at 40 kDa in figure 2 (37o C). The 
decrease in temperature and the small size of FlaD myc may have been the reason for the 
increased solubility. Since lowering the temperature leads to lower general production rate, 
the nascent protein has more time to fold and inducing the culture at 16o C induces the 
expression of chaperones and cold shock protein which helps to maintain solubility and assist 
in folding (Niiranen, Espelid et al. 2007). The small size may also have aided in the solubility 
of FlaD myc because there is less possibility of a misfolding to occur when compared with 
larger protein. The solubility of the recombinant TGs is reduced when expressed at 37o C and 
16o C.  The recombinant TGs cannot be seen in the soluble fraction in the SDS-PAGE 
analysis but can only be detected by immunoblotting. This suggests that the solubilty of the 
protein is low at both temperatures. The reason for this may be a combination of the factors. 
The recombinant protein is bigger in size than FlaD myc (positive control). The bigger sized 
protein requires more time to fold which may introduce error and cause misfolding thus 
making it insoluble. There is optimal temperature for expression of particular protein with its 
fusion tag and these should be investigated when optimizing a protein expression system 
(MacDonald, Armson et al. 2003).  
Another reason why the recombinant protein (TG) cannot be seen in the coomassie staining of 
SDS-PAGE gel is because of the action of the host’s proteases which degrades the protein as 
it is not native. Premature termination, codon bias of the E. coli may also lead the protein to 
not translate properly, there by affecting the solubility of the recombinant protein 
(MacDonald, Armson et al. 2003). The introduction of a fusion protein such as maltose 
binding protein (MBP), N-utilizing substance A (Nus A), thioredoxin, cloned N –terminally to 
the protein of interest could be helpful in solubilizing the recombinant protein. These fusion 
protein also serves as a tag. It was suggested that MBP and Nus A are the best fusion proteins 
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for the recombinant production of a cold adpated protein, and among many other fusion 
proteins tested, Nus A increased the solubility of the protein at 16o C in AI strain and 
solubility was lowest when the recombinant protein was expressed with a hexa-histidine tag 
(Niiranen, Espelid et al. 2007). So to obtain a protein in soluble fraction, parameters such as 
expression strain, protein fusion tag, temperature, inducer concentration has to investigated 
thoroughly. Some reports also suggests that the solubility of the recombinant protein can be 
enhanced by introducing a dipeptide, glyclglycine in the range of 100mM to 1M in the 
medium which enhances the solubility by several folds (Ghosh, Rasheedi et al. 2004). All of 
these factors have to screened for increasing the solubility of the recombinant protein. In 
figure 5 and 6 (immunological analysis of pellet and supernatant fraction at 16oC), two 
additional bands are seen in the insoluble fraction (pellet) of higher molecular weight but no 
additional bands are seen in the supernatant fraction. This may be because the insoluble form 
of the TG has made a complex with other bacterial proteins from the host. The bands which 
are smaller in size can be detected in the immunoblot. The reason may be because of the 
action of protease of the host which degraded the protein.  
The small scale production of the recombinant TG1 and TG2 at both temperature (37o C and 
16o C) showed that TG1 was consistent and was expressed well in comparison to TG2. The 
expression of TG1 was relatively high in soluble fraction when compared to TG2. The two 
TGs are quite similar as TG1 is 78.3 kDa in size whereas TG2 is 78.8 kDa. The difference 
between recombinant TG1 and TG2 is the presence of additional myc tag cloned C-terminally 
to TG1. TG2 lacks it. The influence of myc tag in the expression and solubility of TG1 has to 
be further investigated. 
5.2 Temperature vs. solubility 
There have been a lot of studies and experiments in expressing cold adapted enzymes in 
bacterial expression system. The relationship between temperature and folding of the 
recombinant protein plays an important role in obtaining the recombinant protein in soluble 
and active form. Different studies show different results for the relation between temperature 
and solubility for different cold adapted enzymes.   
One study showed the expression of soluble cold adapted enzyme acetate kinase from 
Shewanella species AS-11 in E. coli BL21 (DE3) was maximum at 20o C when the induction 
was carried out for 16 hours (Md. Abul Kashem Tang 2012) . Different induction temperature 
and time of induction was tested for this experiment. 
Similarly some other report suggests different induction temperature to obtain high yield of 
soluble protein. Different induction temperature was tested to determine the optimum 
temperature and induction time for the production of trypsin I from Atlantic cod in the soluble 
fraction (Jónsdóttir, Bjarnason et al. 2004) . The result suggests that the optimum temperature 
for the induction of expression of HP-thioredoxin trypsin I was found out to be 25o C and the 
optimum time of induction was 10 hours.  
Hartinger et al  reported the expression of a mesophilic mycotoxin fumonisin B(1) in E. coli  
Arctic Express (DE3) which co-expresses two cold adapted chaperons  at 110 C finally 
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resulted in the production of active enzyme (Hartinger, Heinl et al. 2010). This result was 
even better than the expression of the recombinant protein with MBP as fusion partner at 30o 
C.  
These results suggest that induction temperature depends upon the protein of interest. 
Different proteins have their own optimum temperature at which they correctly fold and 
remain in the active form. So the optimum temperature for the protein of interest has to be 
optimized by running a pilot scale at different temperature and different induction time. And 
once it has been established, then only the large scale production and purification steps should 
be carried on.  
       
5.3 Large Scale Production: 
Large scale production of TG1 was carried at 16o C using the same expression system used 
for the small scale production. The supernatant fraction was analyzed for the presence of TG1 
and the pellet was discarded. Immobilized Metal Affinity Chromatography (IMAC) was used 
for the purification of the recombinant protein. The supernatant fraction was run through a 
column comprising of nickel atom which has a high affinity for the polyhistidine present in 
the recombinant protein. The column was washed with varying concentration of imidazole for 
the purpose of displacing the recombinant protein from the column. 
The objective of the purification was to obtain the recombinant protein in a non-denaturing 
state or in a native state. So, the use of imidazole to displace the recombinant protein was 
chosen. At first, the column was washed with a buffer containing imidazole concentration of 
250 mM, with an aim to wash the proteins which were attached nonspecifically. The 
concentration of imidazole in the washing buffer proved too high as it not only washed the 
contamination but also the recombinant protein with it. The final concentration of imidazole 
for washing was determined to be 50mM. The recombinant protein was finally eluted with 
500mM imidazole. 
The hexa-histidine available in the recombinant protein to attach itself to the nickel atom 
present in the His Trap column may have posed little problem. The elution of the recombinant 
protein with even 100 mM imidazole suggests that the bond between the nickel and 
recombinant protein was weak. The histidine tag may have folded into the recombinant 
protein so that fewer histidine was available for the nickel atom in the column.  The amount 
of histidine at the surface should be enough to attach itself to the column. The washing of the 
recombinant protein even with 100mM imidazole suggests that enough histidine may not have 
been present at the surface of the recombinant protein. One reason could be that the histidine 
tag was folded towards the core of the protein which hid the histidine for the interaction with 
the nickel in the column. The interaction between the nickel and histidine could be enchanced, 
if nano-histidine tag is used instead of hexa-histidine. If the number of histidine is nine or 
more, the bond between histidine and nickel might be strong and the washing process would 
be more efficient.   
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6. Future projects: 
The future projects involving TGs could be very interesting. The first step of optimizing the 
expression and purification can be followed from this experiment. The question of low 
concentration of soluble TGs in the supernatant fraction could be addressed by choosing a 
fusion protein as a tag which helps in the solubilizing the recombinant protein. Fusion protein 
such as MBP, Nus A have shown be effective in this situation.  The yield of recombinant TG 
could be increased in these ways.  
The future analysis could be based on the activity of the enzyme. Its activity in catalyzing 
acyl-transfer between the glutamine and lysine residue could be investigated.  Michaelis 
constant Km and Vmax of the enzyme’s reaction can be assayed. The removal of myc epitope 
from the C-terminal of TG1 could also be done by cloning TG1 without the myc epitope. The 
myc epitope may lower the activity of the enzyme which can also be studied.  
Finally, if the purpose of using TGs is solely based in the food industry, expressing TGs from 
psychrophilic (microorganism) origin would be more advantageous than from vertebrates. 
The calcium independency of the microorganisms combined with cold adapted nature of the 
enzyme is a big benefit for the food industry. Microorganisms from the cold habitats could be 
screened for the presence of TGs, and purification steps should be optimized. But the use of 
TGs from non-bacterial origin still has other benefits in different fields than food industry. 
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7. Conclusion: 
The recombinant protein production of an enzyme called transglutaminase from Atlantic cod 
(Gadus morhua) was carried out in this study. The genes for two transglutaminase (TG1 and 
TG2) were cloned in a pET151/D-TOPO vector and expressed in BL21 strain of competent E. 
coli. The gene for Flagellin D (Fla D) was also cloned to a vector with an additional myc tag 
attached to the C terminal and Fla D myc was chosen as a positive control throughout the 
experiments. All of the vectors had his tag cloned N terminally to the gene of the protein.  The 
expression of the recombinant protein was induced at two different temperatures (37o C and 
16o C). The expression was analyzed by SDS-PAGE and immunoblotting. The 
immunoblotting analysis confirmed that a protein size of 80 kDa (TG1) was expressed in the 
soluble fraction at 16o C.   
The large scale production was carried out at 16o C for the recombinant production of TG1. 
The supernatant was used for the purification of the recombinant protein using His Trap 
column. Immobilized metal ion in the His Trap column was used to trap the recombinant 
protein. The column was first washed by 50mM imidazole buffer and the attached protein was 
eluted with 500 mM imidazole buffer. The eluted fraction was analyzed by SDS-PAGE and 
immunoblotting. The immunoblotting showed a band at 80 kDa, which confirmed the 
recombinant protein, was produced and eluted. The SDS-PAGE also confirmed the same 
result. The band from the SDS-PAGE was analyzed for amino acid sequence by Q-TOF (LC-
MS/MS) and the result showed that the protein in the band matched the sequence of TG1.   
The tranglutaminase (TG1) was expressed in BL21 strain of E. coli at 16o C and the protein 
was purified with His Trap column. But the concentration of the soluble TG could still be 
improved and should be investigated further. In future, the activity of the enzyme  should be  
studied.       
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